New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone
Michael Soyka1,21Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-Universität, Munich, Rolling Machines Germany; 2Private Hospital Meiringen, Meiringen, SwitzerlandAbstract: Opioid maintenance therapy is a well-established first-line treatment approach in opioid dependence.Buprenorphine, a partial opioid agonist, has been found b